Skip to content

Nadezhda Davis

NPI 1033269188ActiveIndividual· Nurse Practitioner· Los Angeles, CA

Nurse Practitioner in Los Angeles, California, licensed in CA, with an NPI issued in January 2007. Part D covered 347 prescriptions written in 2024, 70% of them generic. Neurocrine Biosciences, Inc. was the largest of 8 companies reporting payments in 2025, $1,675 in all, mostly food and beverage.

Overview

NPI1033269188
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJan 11, 2007
Last updated in NPPESMar 30, 2026
Certified by providerMar 30, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nurse Practitioner (CA)

Part D prescriptions in 2024

Prescriptions (claims)347 · 357 30-day fills
Patients34
Total drug cost$347,395
Generic share70% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,675 · 65 payments from 8 companies
  • 2024$1,586 · 78 payments from 11 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$1,670 · 64 payments
  • Education$5.45 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other nurse practitioners in Los Angeles

All 550 nurse practitioners in Los Angeles · All nurse practitioners in California